Printer Friendly

ROYCE LABORATORIES, INC. ANNOUNCES GORDON BALTZER AS VICE PRESIDENT OF FINANCE AND BUSINESS DEVELOPMENT

 MIAMI, April 30 /PRNewswire/ -- Royce Laboratories, Inc. (NASDAQ: RLAB) announced today that Gordon B. Baltzer, C.A. has joined Royce as vice president of finance and business development, a newly created position.
 Baltzer, 33, who has considerable experience in the generic drug industry, was previously director of financial planning for Apotex Group of Toronto, Canada. Apotex is an internationally diversified health care group and is the largest wholly Canadian owned pharmaceutical company. Apotex' core business is developing and manufacturing more than 100 generic pharmaceuticals.
 Prior to joining Apotex in 1989, Baltzer was corporate controller for Chemfleet Chemical, Inc., a Canadian wholesale/distributor of liquid chemicals.
 Baltzer is a chartered accountant and is a member of the Institute of Chartered Accountants of Ontario and the Canadian Institute of Chartered Accountants.
 Patrick J. McEnany, the company's president, commented, "In addition to Mr. Baltzer's financial talents that he brings, he will be instrumental in sourcing and evaluating new business opportunities for Royce in the worldwide pharmaceutical markets."
 Royce Laboratories, Inc. is a manufacturer of off-patent prescription and over-the-counter pharmaceuticals.
 -0- 4/30/93
 /CONTACT: Patrick J. McEnany, chief executive officer of Royce Laboratories, 305-624-1500/
 (RLAB)


CO: Royce Laboratories, Inc. ST: Florida IN: MTC SU: PER

JB-AW -- FL004 -- 3184 04/30/93 12:05 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 30, 1993
Words:211
Previous Article:ATRIX LABORATORIES ANNOUNCES SECOND QUARTER AND SIX MONTH RESULTS
Next Article:ROYAL CARIBBEAN CRUISES LTD. ANNOUNCES OVER-ALLOTMENT OPTION EXERCISED
Topics:


Related Articles
ROYCE LABORATORIES NAMES SOKOL VICE PRESIDENT, SALES AND MARKETING
ROYCE LABORATORIES NAMES DR. STEVEN MILLER AS DIRECTOR OF RESEARCH & DEVELOPMENT
A. L. LABORATORIES ANNOUNCES KEY MANAGEMENT APPOINTMENTS AT ITS BARRE-NATIONAL SUBSIDIARY
ROYCE LABORATORIES, INC. NAMES DR. STEVEN MILLER AS VICE PRESIDENT OF RESEARCH & PRODUCT DEVELOPMENT
ROYCE LABORATORIES, INC. ADDS CHARLES J. SIMONS TO BOARD OF DIRECTORS
ROYCE LABORATORIES, INC. APPOINTS ROBERT E. BAND CHIEF FINANCIAL OFFICER
ROYCE LABORATORIES, INC. ADDS HUBERT E. HUCKEL, M.D. TO BOARD OF DIRECTORS
ROYCE LABORATORIES, INC. ADDS OGDEN R. REID TO BOARD OF DIRECTORS
ARQULE APPOINTS ERIC B. GORDON AS PRESIDENT AND CEO; JOSEPH C. HOGAN, JR., PH.D. TO CHAIRMAN OF THE BOARD
ROYCE LABORATORIES, INC. NAMES JACK BLEAU AS VICE PRESIDENT OF SALES AND MARKETING; GENE SOKOL APPOINTED VICE PRESIDENT OF BUSINESS DEVELOPMENT

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters